Deep brain stimulation for gait and postural symptoms in Parkinson's disease

Standard

Deep brain stimulation for gait and postural symptoms in Parkinson's disease. / Pötter-Nerger, Monika; Volkmann, Jens.

in: MOVEMENT DISORD, Jahrgang 28, Nr. 11, 15.09.2013, S. 1609-15.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Vancouver

Bibtex

@article{0b3fbbc1ea6749b887a5b617d8f25d3f,
title = "Deep brain stimulation for gait and postural symptoms in Parkinson's disease",
abstract = "In patients with Parkinson's disease, gait and balance difficulties have emerged as some of the main therapeutic concerns. During earlier stages of the disease, the dopamine-responsive aspects of gait disorder can be treated initially with dopaminergic drugs or deep brain stimulation. However, certain temporal aspects of parkinsonian gait disorder remain therapeutically resistant in both the short term and the long term. In this review, we summarize the effects of deep brain stimulation on gait and postural symptoms in the five currently available targets (subthalamic nucleus, globus pallidus, ventralis intermedius thalamic nucleus, pedunculopontine nucleus, and substantia nigra) and describe programming strategies for patients who are mainly disabled by gait problems.",
keywords = "Deep Brain Stimulation, Gait Disorders, Neurologic, Humans, Parkinson Disease, Postural Balance, Sensation Disorders",
author = "Monika P{\"o}tter-Nerger and Jens Volkmann",
note = "{\textcopyright} 2013 Movement Disorder Society.",
year = "2013",
month = sep,
day = "15",
doi = "10.1002/mds.25677",
language = "English",
volume = "28",
pages = "1609--15",
journal = "MOVEMENT DISORD",
issn = "0885-3185",
publisher = "John Wiley and Sons Inc.",
number = "11",

}

RIS

TY - JOUR

T1 - Deep brain stimulation for gait and postural symptoms in Parkinson's disease

AU - Pötter-Nerger, Monika

AU - Volkmann, Jens

N1 - © 2013 Movement Disorder Society.

PY - 2013/9/15

Y1 - 2013/9/15

N2 - In patients with Parkinson's disease, gait and balance difficulties have emerged as some of the main therapeutic concerns. During earlier stages of the disease, the dopamine-responsive aspects of gait disorder can be treated initially with dopaminergic drugs or deep brain stimulation. However, certain temporal aspects of parkinsonian gait disorder remain therapeutically resistant in both the short term and the long term. In this review, we summarize the effects of deep brain stimulation on gait and postural symptoms in the five currently available targets (subthalamic nucleus, globus pallidus, ventralis intermedius thalamic nucleus, pedunculopontine nucleus, and substantia nigra) and describe programming strategies for patients who are mainly disabled by gait problems.

AB - In patients with Parkinson's disease, gait and balance difficulties have emerged as some of the main therapeutic concerns. During earlier stages of the disease, the dopamine-responsive aspects of gait disorder can be treated initially with dopaminergic drugs or deep brain stimulation. However, certain temporal aspects of parkinsonian gait disorder remain therapeutically resistant in both the short term and the long term. In this review, we summarize the effects of deep brain stimulation on gait and postural symptoms in the five currently available targets (subthalamic nucleus, globus pallidus, ventralis intermedius thalamic nucleus, pedunculopontine nucleus, and substantia nigra) and describe programming strategies for patients who are mainly disabled by gait problems.

KW - Deep Brain Stimulation

KW - Gait Disorders, Neurologic

KW - Humans

KW - Parkinson Disease

KW - Postural Balance

KW - Sensation Disorders

U2 - 10.1002/mds.25677

DO - 10.1002/mds.25677

M3 - SCORING: Journal article

C2 - 24132849

VL - 28

SP - 1609

EP - 1615

JO - MOVEMENT DISORD

JF - MOVEMENT DISORD

SN - 0885-3185

IS - 11

ER -